Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer

• Published in: Nature reviews. Urology Vol. 12; no. 4; pp. 225 - 235
• Main Authors: Kamat, Ashish M., Flaig, Thomas W., Grossman, H. Barton, Konety, Badrinath, Lamm, Donald, O'Donnell, Michael A., Uchio, Edward, Efstathiou, Jason A., Taylor, John A.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.04.2015; Nature Publishing Group
• Subjects: 692/4025/2768/589/1336; 692/700/565/1436; 692/700/565/251; BCG; BCG vaccines; Bladder cancer; Care and treatment; consensus-statement; Dosage and administration; Drug therapy; Evaluation; Immunotherapy; Medicine & Public Health; Methods; Practice guidelines (Medicine); Urology

A focus group of specialized urologic oncologists has reviewed guidelines and clinical evidence and discussed their experiences regarding the optimal use of BCG in the management of patients with NIMBC. Here, they provide a review of BCG therapy, clarify complex related topics and recommend best pra...